Evidence map›Paper›PMID 28255426›Full record

ReviewWorld journal of gastrointestinal oncology2017

Anal intraepithelial neoplasia: A review of diagnosis and management.

Joseph R Roberts, Lacey L Siekas, Andrew M Kaz

Abstract readReview
In one paragraph

Review in World journal of gastrointestinal oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cytology-based Screening for Anal Intraepithelial Neoplasia in Immunocompetent Brazilian Women with a History of High-Grade Cervical Intraepithelial Neoplasia or Cancer.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022
    Article
  18. The Role of Inflammation in Anal Cancer.Diseases (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Is there a higher frequency of anal dysplasia and infection by human papillomavirus in Crohn's disease patients?Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph R RobertsJoseph R Roberts, Andrew M Kaz, Department of Medicine, Division of Gastroenterology, University of Washington School of Medicine, Seattle, WA 98195, United States.
Lacey L SiekasJoseph R Roberts, Andrew M Kaz, Department of Medicine, Division of Gastroenterology, University of Washington School of Medicine, Seattle, WA 98195, United States.
Andrew M KazJoseph R Roberts, Andrew M Kaz, Department of Medicine, Division of Gastroenterology, University of Washington School of Medicine, Seattle, WA 98195, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anal intraepithelial neoplasia (AIN) is a premalignant lesion of the anal mucosa that is a precursor to anal cancer. Although anal cancer is relatively uncommon, rates of this malignancy are steadily rising in the United States, and among certain high risk populations the incidence of anal cancer may exceed that of colon cancer. Risk factors for AIN and anal cancer consist of clinical factors and behaviors that are associated with the acquisition and persistence of human papilloma virus (HPV) infection. The strongest HPV-associated risk factors are HIV infection, receptive anal intercourse, and high risk sexual behavior. A history of HPV-mediated genital cancer, which suggests infection with an oncogenic HPV strain, is another risk factor for AIN/anal cancer. Because progression of AIN to anal cancer is known to occur in some individuals over several years, screening for AIN and early anal cancer, as well as treatment of advanced AIN lesions, is reasonable in certain high-risk populations. Although randomized controlled trials evaluating screening and treatment outcomes are lacking, experts support routine screening for AIN in high risk populations. Screening is performed using anal cytological exams, similar to those performed in cervical cancer screening programs, along with direct tissue evaluation and biopsy

Indexed as

Anal cancerAnal intraepithelial neoplasiaAnal squamous cell carcinomaHuman papillomavirusHuman papillomavirus vaccine

Identifiers

PMID28255426
PMCPMC5314201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.